Navigation Links
Immunosuppressant in Medical News

Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009

...o immunoassay kits for quantitative measurement of immunosuppressant drug levels. Each kit includes reagents, controls,...s some of the analytical weaknesses of immunoassay immunosuppressant drug measurement. The new MassTrak Immun...vailable kit specifically designed to quantify the immunosuppressant tacrolimus in kidney and liver transplant patients...

New Jefferson study may redefine how a chronic auto-immune disease is diagnosed

...osteroids such as prednisone, plasmapheresis (plasma exchange) and intravenous immunoglobulin (IVIg). IVIg may be used even as a first-line therapy. immunosuppressant drug therapy may be effective in patients who fail standard therapy. Physiotherapy may improve muscle strength, balance, function and mobility, and mi...

More stringent evaluation on the use of generic medications in thoracic transplantation

...ier. Thoracic transplant patients require immunosuppressant medications that are classified by regulating agen...tely represent the challenges faced in prescribing immunosuppressant medication in transplant recipients. Many times, t...health care professionals caring for them if their immunosuppressant medication has been changed Education of other...

Leukemia Risk From MS Drug May Be Up

...xantrone (Novantrone), an estimated 7.4 people will develop acute leukemia, compared with fewer than 2.5 people in prior estimates. Mitoxantrone is an immunosuppressant approved by the U.S. Food and Drug Administration for treatment of secondary progressive MS. In the study, about 0.74 percent of people taking the ...

Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought

...e Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 - May 2, 2009. Mitoxantrone is an immunosuppressant drug approved by the FDA for treatment of several forms of advancing MS. It is one of only two drugs that has been shown to benefit people with second...

Mayo Clinic researchers formulate treatment combination lethal to pancreatic cancer cells

...ready available for treatment of patients. Panobinostat is approved as therapy for cutaneous T cell lymphoma (CTCL), and rapamycin is best known as an immunosuppressant to help prevent rejection of transplanted organs. "We need new therapies and strategies for the treatment of pancreatic cancer because these tumors...

Study reports success in treating a rare retinal disorder

...y patients are undertreated because we do not have good markers to evaluate treatment effects," observes Heckenlively. "Now that we have evidence that immunosuppressant therapies work, we need further studies to evaluate which medications will be effective in treating autoimmune retinopathy." ...

Stem Cells Repair Damaged Corneas in Mice

...h could mean a shortage in years to come, Funderburgh said. Transplanted corneas have a low risk of rejection, and patients don't even need to take immunosuppressant drugs, Bensinger said. But because of the characteristics of scar tissue, people with corneal injuries are often not good candidates for corneal trans...

ADVENTRX Grants Exclusive Rights to ANX-514 in South Korea

...sitivity reactions. Docetaxel is an anti-cancer agent that acts by disrupting the cellular microtubular network that is essential for cell division. immunosuppressant premedication is recommended for docetaxel therapy to reduce the incidence and severity of hypersensitivity reactions. Docetaxel is approved to treat...

Licorice May Block Absorption of Organ Transplant Drug

...y finds potential interaction with cyclosporine could lead to fatal complications TUESDAY, March 24 (HealthDay News) -- People taking the immunosuppressant cyclosporine should avoid consuming licorice because it may weaken the drug's effectiveness and possibly lead to deadly consequences, new research sug...
Immunosuppressant in Medical Technology

ADVENTRX Announces Results From ANX-514 Bioequivalence Study

...nsitivity reactions. Docetaxel is an anti-cancer agent that acts by disrupting the cellular microtubular network that is essential for cell division. immunosuppressant premedication is recommended for docetaxel therapy to reduce the incidence and severity of hypersensitivity reactions. Docetaxel is approved to treat...

Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy

...ad to end-stage renal disease requiring dialysis or kidney transplant. Current treatments for IgA nephropathy include blood pressure control, diet and immunosuppressant drugs. Approximately 30 percent of IgA nephropathy patients do not respond to current therapies. About Osprey Pharmaceuticals U.S.A. ...

ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study

...ensitivity reactions. Docetaxel is an anti-cancer agent that acts by disrupting the cellular microtubular network that is essential for cell division. immunosuppressant premedication is recommended for docetaxel therapy to reduce the incidence and severity of hypersensitivity reactions. Docetaxel is approved to treat ...

Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment

...ignancies in patients treated with a TNF antagonist cannot be excluded. All patients, and in particular patients with a medical history of extensive immunosuppressant therapy or psoriasis patients with a history of PUVA treatment, should be examined for the presence of non-melanoma skin cancer prior to and during tr...

CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI

... cases generally had risk factors for PML, including treatment with immunosuppressant therapies and impairment of immune function. In immunosuppressed patien...d not use CellCept unless she cannot be successfully treated with other immunosuppressant drugs. If this drug is used during pregnancy, or if the patient becomes...

Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function

... cases generally had risk factors for PML, including treatment with immunosuppressant therapies and impairment of immune function. In immunosuppressed patie...d not use CellCept unless she cannot be successfully treated with other immunosuppressant drugs. If this drug is used during pregnancy, or if the patient become...

Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG)

...at improving both the laboratory and the clinical manifestations of the MG equivalent in rats. The authors concluded that "pixantrone [is] a promising immunosuppressant agent suitable for clinical investigation in myasthenia gravis, although additional experiments are needed to confirm its safety profile in prolonged ...

Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis

...y prescribed to patients undergoing treatment for inflammatory arthritis, including those that were being taken by the patient, are recognized to have immunosuppressant effects. About tgAAC94 and the Phase I/II Study tgAAC94 is being developed as a supplemental therapeutic to systemic anti-TNF-alpha protein therapy ...

Isotechnika's independent data monitoring committee conducts review of phase 2b kidney transplant trial

... autoimmune diseases and for use in the prevention of organ rejection in transplantation. Isotechnika looks to become the leader in development of immunosuppressant therapies. Isotechnika's lead compound, ISA247 has successfully completed a Phase 3 Canadian trial for the treatment of moderate to severe psorias...

Low-Dose Steroid Combined With Lenalidomide Prolongs Survival Compared With High-Dose Steroid for Multiple Myeloma Treatment

... myeloma in patients who received at least one prior therapy for their disease. Dexamethasone is a steroid that acts as an anti-inflammatory and as an immunosuppressant and has numerous uses in medical practice. ECOG has a long history in developing new treatments for multiple myeloma, according to Robert L. Comis, ...
Immunosuppressant in Medical Products

Lyphochek Elevated Immunosuppressant Control

Description: Lyphochek Elevated Immunosuppressant Control is a bilevel Cyclosporine control product, prepared from human whole blood. This unique product is ideal for use with assay methods that monitor very high Cyclosporine levels, such as C2 monitoring, which measures Cyclosporine levels in transplant patien...
Company:Bio-Rad Laboratories
Immunosuppressant in Medical Dictionary

Immunosuppressant drugs

...d in immunosuppressive therapy to: More about immunosuppressant Drugs : Purpose Recommended dosage Precautions Side effects Interactions Resources immunosuppressant Drugs Definition More about immunosuppressant Drugs : Definition Purpose Recommended dosage Pr...
Immunosuppressant in Biological News

Promising 3-year data: Saving limbs with drug-eluting stents

...cal limb ischemia and who underwent infrapopliteal revascularization with angioplasty and placement of either a drug-eluting stent (with sirolimus, an immunosuppressant drug) or a bare-metal stent (without a drug coating). The patients had regular follow-ups up to three years, and researchers studied how they did by s...

Cancer-causing gene discovery suggests new therapies

... already available to counter this increased protein production could slow or stop cancer's runaway growth induced by Myc. Rapamycin, for example, an immunosuppressant drug already in clinical trials for cancer, might help treat cancers where Myc is over active, the scientists suggest. The discovery was led by Dav...

Researchers engineer pancreatic cell transplants to evade immune response

...herapy is limited because transplant recipients are forced to take powerful immunosuppressant medications that have toxic side effects and raise the risk of infection. T...Although such transplants can control type 1 diabetes, recipients must take immunosuppressant medications in order to prevent rejection of these beta foreign cells. "Ul...

REGiMMUNE receives $12 million in grants to develop transplant and allergy drugs

...E will develop its reVax drug for cedar allergy; and the three-year grant from NIBIO will fund the development of its ToleroVax drug (RGI-2001), a new immunosuppressant for Graft-versus-Host Disease (GvHD) associated with stem cell transplantation. "The substantial funds that REGiMMUNE is receiving from these two p...

Top biophysics award to Professor Ray Norton

...ief drugs based on marine cone snail toxins may be able to break the link with such long-term dependence. The sea anemone, from which an effective immunosuppressant has been obtained, could assist in the treatment of multiple sclerosis one key characteristic of this disease being the errant immune system's destru...

Adult stem cells activated in mammalian brain

...of drugs to prevent the body from rejecting the treatment. But, working with a patient's own cells would eliminate the need for transplantation and immunosuppressant drugs and may be a better alternative, scientists say. Ependymal cells line the fluid-filled ventricles, so a drug to activate the cells could theoret...

Engineer develops detergent to promote peripheral nerve healing

...etween the two ends of the severed nerve to promote regrowth. And because the immunogenic lipid components have been extracted, patients don't require immunosuppressant drugs. AxoGen learned about the detergent processing work in Schmidt's lab, licensed it and combined it with the University of Florida enzyme treat...

Promising new drug targets identified for Huntington's disease

...m building up. However, there are currently no treatments available that slow the neurodegeneration in people with Huntington's disease. Rapamycin, an immunosuppressant used to lower the body's natural immunity in patients who receive kidney transplants, is the most promising candidate drug currently available but can...

Immunosuppressant further linked to birth defects

...d taken mycophenolate mofetil (MMF), a widely used immunosuppressant available commercially as Cellcept. The findings s...ve not occurred. The fetal side-effects of several immunosuppressant drugs have been studied, though not for widely use...d newer medications, such as (MMF). The use of immunosuppressant drugs is a required, life-long treatment for solid...

Genetic technology reveals how poisonous mushrooms cook up toxins

...biochemical pathways by which natural products are synthesized in fungi. Fungal natural products that benefit human health include penicillin and the immunosuppressant drug cyclosporin. Studying their biosynthesis could lead to the discovery and development of new medicines. To find the elusive gene for alpha-aman...
Immunosuppressant in Biological Technology

A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA)

Purpose A previously published application note in this series describes an LC/MS/MS method for the simultaneous determination of four immunosuppressant drugs: Cyclosporin A (CsA), Tacrolimus (TAC, aka FK-506), Sirolimus (SIR, aka Rapamycin) and Everolimus (EVE, aka RAD-001) ...

Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients

...he FDA in March 2006. (Logo: http://www.newscom.com/cgi-bin/prnh/20090528/SF23579LOGO ) "Prograf + MMF has been an accepted and successful immunosuppressant regimen for the transplant community for more than 10 years," said Flavio Vincenti, M.D., Professor of Clinical Medicine, University of California, S...

New Biologic STELARA(TM) Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis

...panies have exclusive marketing rights in all countries outside of the United States. Important Safety Information STELARA is a selective immunosuppressant and may have the potential to increase the risk of infections and reactivate latent infections. Serious infections have been observed in patients rec...

ADVENTRX Announces Further Cost-Cutting Measures

...ensitivity reactions. Docetaxel is an anti-cancer agent that acts by disrupting the cellular microtubular network that is essential for cell division. immunosuppressant premedication is recommended for docetaxel therapy to reduce the incidence and severity of hypersensitivity reactions. Docetaxel is approved to treat ...

University of Minnesota Receives $40 Million for Type 1 Diabetes Research

...ersity of Minnesota researchers have sought a cure for type 1 diabetes through developing both an abundant supply of islet cells and better and safer immunosuppressant techniques. A team led by David Sutherland, M.D., Ph.D., co-director of the Schulze Diabetes Institute and founder of the former DIIT, was the...

Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis

...alignancies in patients treated with a TNF antagonist cannot be excluded. All patients, and in particular patients with a medical history of extensive immunosuppressant therapy or psoriasis patients with a history of PUVA treatment, should be examined for the presence of non-melanoma skin cancer prior to and during tr...
Other Tags
(Date:5/29/2015)... 2015 The Healthcare Delivery Institute ... its Advanced Training Program (ATP) in Healthcare Delivery ... in their health care organization ranging from clinicians ... of continuous quality improvement in the health care ... Brent James’ internationally recognized Advanced Training Program at ...
(Date:5/29/2015)... Inspire Nexus, a new social network officially launching June ... life coaches have asked, "How do I find coaching ... become a credentialed Coach?" , Many Life and Career ... Inspire Nexus, a social network for Coaches provides members ... experience coaching a certain number of hours, qualify to ...
(Date:5/29/2015)... NY (PRWEB) May 29, 2015 The ... as well as a number of specific concerns within, ... stigma reduction and mental health in the workplace. We ... mental health. The campaign also brings special focus to ... individuals to speak up and seek help from healthcare ...
(Date:5/29/2015)... Dallas, TX (PRWEB) May 29, 2015 ... H1 2015” provides comprehensive information on the therapeutic ... different types of muscles in the body, leading ... strengthens R&D pipelines by identifying new targets and ... report on H1 2015 pipeline review of Axillary ...
(Date:5/29/2015)... The Croatia Cosmetic Dentistry Center - ... on what modern dentistry options are available today. The ... to revolutionize the perception of a dental practice — ... Spa. , The top dental provider is partnered ... tourism agencies and led by world-renowned experts, Dr. ...
Breaking Medicine News(10 mins):Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 2Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 3
(Date:5/21/2015)... 2015 The Sync Project™ , a ... health, today announced a collaborative partnership with Berklee,s ... center on collaboration on original research, joint course development ... the collaboration, The Sync Project and BerkleeICE are exploring ... in the 2015-2016 academic year.  The ...
(Date:5/20/2015)... Conn. , May 20, 2015 NXT-ID, ... announces that its wholly owned subsidiary, 3D-ID LLC, a ... under Team Battelle for the biometrics technology portion of ... Suite Contract from the Department of the Army. ... recognition products developed for government, law enforcement and security ...
(Date:5/19/2015)... 19, 2015  Technology is rapidly advancing, outpacing enterprises, ... the cloud. Passwords and their management are soon to ... standards-based specifications such as those developed by the FIDO ... passwords presents for BYOD, COPE, IoT, and mobile payments, ... protocol. In response to the call ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
Other Contents